Palisade Bio Inc Sustainability Reports
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company focused on identifying and developing therapeutics that protect the integrity of the gastrointestinal mucosal barrier.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 549300W6LIDX3I5XXT34
2 reports from 2022 to 2023
Company Profile
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company focused on identifying and developing therapeutics that protect the integrity of the gastrointestinal mucosal barrier.
Reports
2 total
Limited sustainability disclosure available
This company only publishes Annual Reports without dedicated sustainability sections.
